BREAST CANCER (LOCALLY ADVANCED OR METASTATIC)
Clinical trials for BREAST CANCER (LOCALLY ADVANCED OR METASTATIC) explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER (LOCALLY ADVANCED OR METASTATIC) trials appear
Sign up with your email to follow new studies for BREAST CANCER (LOCALLY ADVANCED OR METASTATIC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tattoos could help breast cancer patients avoid mastectomy
Disease control Recruiting nowThis study tests whether tattooing the edges of breast tumors before chemotherapy helps surgeons remove the cancer completely while saving the breast. About 30 women with advanced breast cancer will get their tumor margins marked with tattoo ink and sometimes a small clip. After …
Matched conditions: BREAST CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: NA • Sponsor: All India Institute of Medical Sciences, Bhubaneswar • Aim: Disease control
Last updated May 17, 2026 05:49 UTC
-
New shot targets tough cancers: early trial seeks 150 patients
Disease control Recruiting nowThis early-stage study tests a new drug called SH009 in about 150 people with advanced solid tumors (like liver, lung, or breast cancer) that have not responded to standard treatments. The main goal is to see if the drug is safe and can shrink tumors. Researchers will also measur…
Matched conditions: BREAST CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: PHASE1 • Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
Immune cell therapy takes on Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment called EBNK-001, which uses donor natural killer (NK) cells to fight advanced solid tumors. About 83 adults with cancers like lung, breast, or colorectal cancer that have not responded to standard treatments will receive the NK cells along with ch…
Matched conditions: BREAST CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: PHASE1, PHASE2 • Sponsor: Essen Biotech • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Engineered immune cells take on Hard-to-Treat breast cancers
Disease control Recruiting nowThis study tests a new treatment using specially designed immune cells (CAR-NK cells) that target specific markers on breast cancer cells. It is for people with advanced HER2-positive or triple-negative breast cancer who have not responded to standard therapies. The goal is to se…
Matched conditions: BREAST CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
AI app aims to ease cancer treatment burden
Symptom relief Recruiting nowThis study tests a smartphone app called ASSIST that uses artificial intelligence to help people with breast cancer, lymphoma, or colorectal cancer manage symptoms during treatment. About 60 adults starting or recently starting systemic therapy will either use the app for 12 week…
Matched conditions: BREAST CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: NA • Sponsor: Patrick C. Johnson, MD • Aim: Symptom relief
Last updated May 14, 2026 12:03 UTC